1. Home
  2. MDGL vs ESI Comparison

MDGL vs ESI Comparison

Compare MDGL & ESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • ESI
  • Stock Information
  • Founded
  • MDGL 2011
  • ESI 1922
  • Country
  • MDGL United States
  • ESI United States
  • Employees
  • MDGL N/A
  • ESI N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • ESI Major Chemicals
  • Sector
  • MDGL Health Care
  • ESI Industrials
  • Exchange
  • MDGL Nasdaq
  • ESI Nasdaq
  • Market Cap
  • MDGL 6.8B
  • ESI 6.3B
  • IPO Year
  • MDGL N/A
  • ESI N/A
  • Fundamental
  • Price
  • MDGL $319.93
  • ESI $20.55
  • Analyst Decision
  • MDGL Buy
  • ESI Strong Buy
  • Analyst Count
  • MDGL 9
  • ESI 9
  • Target Price
  • MDGL $386.29
  • ESI $28.22
  • AVG Volume (30 Days)
  • MDGL 333.2K
  • ESI 4.4M
  • Earning Date
  • MDGL 05-01-2025
  • ESI 04-23-2025
  • Dividend Yield
  • MDGL N/A
  • ESI 1.58%
  • EPS Growth
  • MDGL N/A
  • ESI 118.34
  • EPS
  • MDGL N/A
  • ESI 1.18
  • Revenue
  • MDGL $180,133,000.00
  • ESI $2,475,600,000.00
  • Revenue This Year
  • MDGL $230.69
  • ESI N/A
  • Revenue Next Year
  • MDGL $74.76
  • ESI $5.70
  • P/E Ratio
  • MDGL N/A
  • ESI $19.22
  • Revenue Growth
  • MDGL N/A
  • ESI 6.08
  • 52 Week Low
  • MDGL $189.00
  • ESI $16.77
  • 52 Week High
  • MDGL $377.46
  • ESI $29.78
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 50.76
  • ESI 48.54
  • Support Level
  • MDGL $276.20
  • ESI $17.77
  • Resistance Level
  • MDGL $330.64
  • ESI $19.21
  • Average True Range (ATR)
  • MDGL 20.79
  • ESI 1.28
  • MACD
  • MDGL 0.06
  • ESI 0.28
  • Stochastic Oscillator
  • MDGL 76.56
  • ESI 97.05

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company has two segments which are Electronics and Industrial & Specialty. The Industrial & Specialty segment which generates majority of the revenue, includes chemical systems that protect and decorate metal and plastic surfaces; consumable chemicals that enable printing image transfer on flexible packaging materials; and chemistries used in water-based hydraulic control fluids in offshore energy production. Electronics segment researches, formulates and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging.

Share on Social Networks: